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Hypohidrotic ectodermal dysplasia (HED), a congenital disorder of teeth, hair, and eccrine sweat glands, is usually
inherited as an X-linked recessive trait, although rarer autosomal dominant and recessive forms exist. We have
studied males from four families with HED and immunodeficiency (HED-ID), in which the disorder segregates as
an X-linked recessive trait. Affected males manifest dysgammaglobulinemia and, despite therapy, have significant
morbidity and mortality from recurrent infections. Recently, mutations in IKK-gamma (NEMO) have been shown
to cause familial incontinentia pigmenti (IP). Unlike HED-ID, IP affects females and, with few exceptions, causes
male prenatal lethality. IKK-gamma is required for the activation of the transcription factor known as “nuclear
factor kappa B” and plays an important role in T and B cell function. We hypothesize that “milder” mutations
at this locus may cause HED-ID. In all four families, sequence analysis reveals exon 10 mutations affecting the
carboxy-terminal end of the IKK-gamma protein, a domain believed to connect the IKK signalsome complex to
upstream activators. The findings define a new X-linked recessive immunodeficiency syndrome, distinct from other
types of HED and immunodeficiency syndromes. The data provide further evidence that the development of ec-
todermal appendages is mediated through a tumor necrosis factor/tumor necrosis factor receptor–like signaling
pathway, with the IKK signalsome complex playing a significant role.
The molecular basis of the ectodermal dysplasias, a
group of inherited disorders involving absence or dys-
plasia of the ectodermal appendages, is steadily being
discovered. The hypohidrotic or anhidrotic forms dis-
play abnormal development of eccrine sweat glands,
teeth, and hair (Freire-Maia and Pinheiro 1988). Hy-
pohidrotic ectodermal dysplasia (HED) is usually inher-
ited as an X-linked recessive trait (ED1 [MIM 305100]),
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although rarer, autosomal dominant (ED3 [MIM
129490]) and autosomal recessive (MIM 224900) forms
exist. Ectodysplasin-A, the product of the X-linked lo-
cus, is a member of the tumor necrosis factor (TNF)
ligand superfamily (Monreal et al. 1998; Ezer et al.
1999), whereas the protein product of one of the au-
tosomal forms is a member of the TNF-receptor (TNFR)
superfamily (Headon and Overbeek 1999; Monreal et
al. 1999). Recently, another disorder classified as an ec-
todermal dysplasia, familial incontinentia pigmenti (IP)
(IP2 [MIM 308310]), has been shown to be due to mu-
tations in IKK-gamma (NEMO) (Smahi et al. 2000).
IKK-gamma is required for the activation, and subse-
quent translocation to the nucleus, of the transcription
factor NF-kB, where NF-kB activates multiple target
genes (Rothwarf et al. 1998; Yamaoka et al. 1998).
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Figure 1 Pedigrees of families with HED-ID. Black squares de-
note affected males; circles containing dots denote carrier females. ()
p Mutant allele; () p wild-type allele.
Members of the TNF cytokine family are among mul-
tiple intra- and extracellular stimuli that can activateNF-
kB. NF-kB is sequestered in the cytoplasm by I-kB, an
inhibitory molecule that, on activation of the pathway,
is phosphorylated and degraded by a multiprotein ki-
nase complex, of which IKK-gamma is an essential reg-
ulatory component (Israel 2000). The importance of
IKK-gamma for normal T and B cell development is
supported by data from IKK-gamma knockout mice
(Makris et al. 2000; Rudolph et al. 2000; Schmidt-Sup-
prian et al. 2000), as well as by the findings of immu-
nodeficiency in a rare surviving male patient with a mu-
tation within IKK-gamma (Smahi et al. 2000). We have
encountered the uncommon combination of HED and
immunodeficiency (HED-ID) in males from four unre-
lated families. Although there have been rare reports of
significant immunodeficiency in males with putative X-
linked HED (Abinun et al. 1996; Schweizer et al. 1999),
we have seen no immunodeficiency in males from fam-
ilies with known mutations at the ED1 (Xq13.1) locus
(Clarke et al. 1987; Monreal et al. 1998). In addition,
defects of the eccrine sweat glands, teeth, or hair are not
present in males with known X-linked immunodefi-
ciency syndromes (Conley 1994; Puck 1994; Smart and
Ochs 1997). This has led us to hypothesize that HED-
ID is a distinct X-linked recessive disorder. Even though
the common IKK-gamma mutations seen in IP are lethal
for males in utero, we hypothesize that mutations that
preserve some IKK-gamma function may be responsible
for HED-ID.
Families with HED-ID were identified at clinical cen-
ters and were recruited into a research study approved
by the institutional review board of Oregon Health Sci-
ences University. Consent was obtained for the use of
clinical information, relevant family history, photo-
graphs, and DNA samples. Family histories and clinical
data were provided by the collaborating centers. The
proband of family 1 (III-1; see fig. 1) presented, during
the 1st year of life, with recurrent infections and had
repeated hospitalization for pneumonia and bacterial in-
fections of both bone and soft tissues. Immunoglobulin
levels at age 10 mo showed abnormally low levels of
IgG (!200 mg/dl [normal range 294–1,069 mg/dl]), low-
to-normal levels of IgA, and elevated levels of IgM
(1,100 mg/dl [normal range 41–149 mg/dl]). The re-
mainder of his immunological evaluation was essentially
normal, and he was begun on intravenous gammaglob-
ulin (IVIG) therapy. An inability to sweat had been not-
ed since infancy, requiring lifelong cooling measures.
Dental examination at age 12 years showed absence of
seven teeth from his secondary dentition, on dental ra-
diographs, as well as conical-shaped maxillary lateral
incisors. The patient had periorbital wrinkling of the
skin but normal scalp hair. Despite intensive treatment,
he developed bronchiectasis with pulmonary insuffi-
ciency, and he died at age 17 years, after bilateral lung
transplantation. The proband’s younger maternal half-
brother (III-2; see fig. 2a) was studied during infancy
and was found to have a similar dysgammaglobulinemia,
with low levels of IgG and elevated IgM levels. He was
begun on IVIG but still experienced hospitalizations be-
cause of recurrent bacterial infections. He had conical-
shaped incisors, hypodontia (missing four of his per-
manent teeth), and normal scalp hair, and, because
inadequate sweating, he required special cooling mea-
sures. The mother of these two patients (II-2) had a
normal results on examination and an unremarkable
family history.
The proband of family 2 (III-1; see fig. 2b) presented,
at age 28 mo, after developing pneumococcal meningitis
and pneumonia. His history was remarkable for recur-
rent cellulitis, soft-tissue abscesses, and sepsis since age
2 wk. Initial laboratory evaluation included a normal
lymphocyte phenotype, except for increased circulating
B cells (33%), IgG 1,030 mg/dl with normal levels of
IgG subclasses, elevated levels of IgA (401–771 mg/
dl), and normal levels of both IgM (45 mg/dl) and IgE
(54 IU/ml). Karyotype, neutrophil oxidative burst, com-
plement (CH50), properidin level, and antibody re-
sponse to immunization with tetanus toxoid were nor-
mal. However, isohemagglutinin titers and specific
antibody production to pneumococcal polysaccharide
were absent. In vitro lymphocyte proliferative responses
were poor initially but subsequently normalized. Despite
administration of IVIG, the patient developed pneu-
mococcal sepsis, recurrent pneumonia, and giardiasis.
He was noted to have conical teeth, decreased sweating,
normal scalp hair, and dry skin with some areas of hy-
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Figure 2 Affected males from each family: HED-ID 1 (a), HED-ID 2 (b), HED-ID 3 (c), and HED-ID 4 (d). Note the hypodontia and
conical-shaped teeth and the periorbital wrinkling and darkening in panels a and c. Scalp hair of the affected individuals is variable, with a
normal appearance in panels a and b, mild thinning in panel c, and sparse thin hair in panel d.
popigmentation. Because of the family history, the pro-
band’s maternal half-brother (III-2) was evaluated at age
8 mo, and initial evaluation revealed increased circulat-
ing B cells (36%), elevated levels of both IgG (1,090 mg/
dl) and IgA (668 mg/dl), normal levels of IgM (70 mg/
dl), and undetectable IgE. Monthly IVIG therapy was
begun, but the patient subsequently developed recurrent
pneumococcal meningitis, multiple pneumonias, cellu-
litis, and a soft-tissue abscess. At age 6.5 years, isohem-
agglutinin levels and results of lymphocyte phenotyping
were normal. The patient had fine sparse hair, dry skin,
decreased sweating, conical teeth, and no evidence of
osteopetrosis. The mother of these two patients (II-2)
has conical teeth and dry skin, as well as elevated levels
of IgA (498 mg/dl). A maternal male cousin (III-3) pre-
sented, at age 12 mo, with clinical and laboratory find-
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ings similar to those of his affected cousins. CD40 ligand
and CD69 expression on stimulated T cells were normal.
This cousin’s mother (II-4) has conical teeth, some var-
iable hyperpigmented lesions of the skin, and elevated
levels of IgA (542 mg/dl).
In family 3, the proband (III-1) was first admitted to
the hospital at age 8 mo, with viral meningitis, with
subsequent admissions for pneumococcal meningitis. At
age 20 mo, his IgA (3.1 g/liter [normal range 0.3–1.3 g/
liter]) and IgM (7.94 g/liter [normal range 0.5–2.2 g/
liter]) levels were elevated, and both his IgG levels and
IgG2 (0.25 g/liter [normal range 0.3–2.9 g/liter]) levels
were low. He failed to form antibodies in response to
pneumococcal vaccine and was begun on IVIG therapy.
Sparse hair, inability to sweat, conical teeth, and absence
of 10 primary teeth were noted. Radiographs of his per-
manent dentition revealed only 15 teeth, some of which
were hypoplastic. Despite therapy, he has had chronic
lung infections with resultant bronchiectasis and pul-
monary insufficiency. There is no other family history
of immunodeficiency, but his mother has only 25 per-
manent teeth and a large patch of skin with neither hair
nor sweating response. The proband of family 4 (III-1;
see fig. 1) presented, at age 2 d, with Pseudomonas bac-
teremia and, because of bacterial infections, was hos-
pitalized multiple times during the 1st year of life. A
thymic shadow was noted on x-ray, as was an increased
bone density consistent with osteopetrosis. Laboratory
studies at age 4 mo age demonstrated low levels of both
IgG (143 mg/dl [normal range 280–750 mg/dl]) and
IgA (8 mg/dl [normal range 6–50 mg/dl]) but high levels
of IgM (221-868 mg/dl [normal range 15–70 mg/dl).
Normal numbers of B, T, and NK cells were present,
and lymphocyte-proliferation studies showed a good re-
sponse to mitogens. Karyotype, nitroblue tetrazolium
testing, and C3, C4, and CH50 levels were normal. He
was noted to have reduced sweating, thin sparse scalp
hair and eyebrows, and mild frontal bossing (fig. 2d).
His dentition was abnormal, and, at age 20 mo, only
two widely spaced conical upper incisors had erupted.
Dental x-rays revealed only two conically shaped upper
incisors, and either absence or extreme hypoplasia of all
four lower incisors. The patient was treated with IVIG
therapy but developed diffuse mycobacterial granuloma-
tosis and died at age 2 years. The proband’s younger
maternal half-brother (III-2) presented, at age 3mo, with
bacterial sepsis and meningitis. Immunoglobulin lev-
els were abnormal, with low levels of both IgG (154 mg/
dl) and IgA (15 mg/dl) but with elevated levels of IgM
(251–888 mg/dl). Lymphocyte proliferation and results
of phenotyping were essentially normal, as were CD40
ligand expression, nitroblue tetrazolium testing, and lev-
els of properdin, adenosine deaminase, and nucleoside
phosphorylase. The patient had osteopetrosis, sparse
scalp hair, and only two conical-shapedmaxillary central
incisors. Similar to his brother, he had very low amounts
of sweat on a quantitative sweat test. He developed
pneumocystis carinii pneumonia and disseminated my-
cobacterium avium intracellulare infection and died at
age 33 mo. The mother of these two patients had normal
dentition, scalp and body hair, and breast development,
and her family history was unremarkable for features of
either ectodermal dysplasia or immunodeficiency.
Mutation analyses of IKK-gamma were performed by
PCR amplification of genomic DNA from males in each
family, by use of previously published primer sets (Smahi
et al. 2000) and Taq DNA Polymerase (Qiagen). PCR
products were sequenced in both directions by an ABI
373 stretch sequencer (Applied Biosystems). Allele-spe-
cific oligonucleotides for each mutant and its corre-
sponding wild-type sequence were hybridized against
PCR products of exon 10 amplified from the genomic
DNAs of family members and 30 unrelated unaffected
females (60 X chromosomes), by previously published
methods (Ferguson et al. 1998). RNA was extracted
(Ambion) from a lymphoblastoid cell line established
from an affected male from family 2. It was reversed
transcribed by Moloney murine leukemia virus reverse
transcriptase (New England Biolabs) and random hex-
amers. The DNA product was amplified by use of oli-
gonucleotides F 5′-GCCTATCACCAGCTCTTCCA-3′
and R 5′-CCCGTGTGCATGGTAAGAG-3′, were hemi-
nested with R 5′-ACCAGCGGATCAACAGCTGAA-3′,
and subsequently were sequenced in both directions.
The IKK-gamma sequence from genomic DNA of af-
fected males from all four families revealed single-base-
pair variants within exon 10 (fig. 3). Exon 10 is the most
3′ exon of IKK-gamma, and the variants are all within
the open reading frame (Jin and Jeang 1999). As has
been noted elsewhere (Smahi et al. 2000), males hemi-
zygous for mutations appear to be heterozygous on ge-
nomic sequence analysis, because of the presence of a
highly conserved, nonexpressed, IKK-gamma pseudo-
gene. The pseudogene contains only a duplication of
exons 3–10, and our attempts at preferential amplifi-
cation of the expressed sequence from genomic DNA
were unsuccessful. As expected, sequences derived from
cDNA isolated from a lymphoblastoid cell line from a
male in family 2 showed only the variant T at nucleotide
1171 (data not shown). Variants cosegregated with the
disorder in all multiplex families and occurred de novo
in family 3 (fig. 1). Variants were not detected in the 60
unrelated control X chromosomes.Mutations in families
2 and 4 produce a nonsense mutation at codon 391
(E391X) and a frameshift at codon 390, respectively,
within the carboxy-terminal end of the 419-amino-acid
protein. The frameshift is the result of an insertion of a
cytosine (1167–1168insC) within a wild-type run of
seven cytosines and introduces novel amino acids at co-
dons 390–393, as well as a premature stop at codon
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Figure 3 Relevant mutant (upper graphs) and wild-type (lower graphs) genomic sequence from each family. Note that affected hemizygous
males appear to be heterozygous, because of a highly homologous IKK-gamma pseudogene.
394. Both mutations truncate the protein and delete
a putative zinc-finger domain (amino acids 397–417)
(Smahi et al. 2000). A western blot of an extract from
a lymphoblastoid cell line derived from family 2 dem-
onstrates that the protein is expressed (data not shown).
The variants in families 1 (C417R) and 3 (C417F) are
nonconserved missense mutations within the putative
zinc-finger domain and alter a common cysteine residue
to an arginine and a phenylalanine, respectively.
The molecular and clinical findings in these families
establish HED-ID as a distinct X-linked recessive dis-
order. The phenotype and genetics (recessive vs. domi-
nant) of HED-ID differ significantly from those of fa-
milial IP. Even though they are allelic disorders, it may
be more clinically useful to distinguish the phenotypes
and, thus, to refer to affected males as having HED-ID
rather than IP. The clinical findings of hypohidrosis and
abnormal dentition are similar to those seen in other
forms of HED (Clarke et al. 1987; Munoz et al. 1997),
although the involvement of the scalp hair is more var-
iable. These findings explain the previous reports that
imply that serious immunodeficiency may be a compli-
cation of the more common X-linked form of HED
(ED1) (Abinun et al. 1996; Schweizer et al. 1999). How-
ever, immunodeficiency is absent even in males with no
ectodysplasin-A protein, the product of the ED1 locus
(Thomas et al. 1993; Monreal et al. 1998). HED-ID is
also distinct from other X-linked immunodeficiencies,
even though the immunoglobulin levels in families 1 and
4 originally suggested a diagnosis of hyper-IgM syn-
drome (MIM 308230). However, CD40 ligand expres-
sion, measured in families 2 and 4, was normal. Males
from all four families presented, during the first 2 years
of life, with life-threatening infections, continued to have
recurrent infections despite IVIG therapy, and, because
of recurrent pulmonary infections and bronchiectasis,
have had significant morbidity and mortality. It is note-
worthy that a male with features of HED-ID has recently
been reported to have also undergone bilateral lung
transplantation (Smythe et al. 2000). Although there is
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variability, in the clinical and laboratory findings, among
the four families, all patients had either normal or in-
creased numbers of B cells and had normal T cell num-
bers and proliferation. Dysgammaglobulinemia with
normal to low levels of IgG and with elevated levels of
either IgA or IgM was a consistent finding. Delayed or
absent production of isohemagglutinins, as well as an
inability to form specific antibody to Streptococcus
pneumoniae, are other common features. Previous re-
ports in the literature have described a few males with
HED-ID who are also characterized by both an impaired
ability to respond to polysaccharide-type antigens and
either low or absent isohemagglutinins (Abinun et al.
1996; Schweizer et al. 1999). The clinical findings in
family 4 were the most severe, with death occurring by
age 3 years. The findings in this family, including osteo-
petrosis, are similar to those in a rare surviving male
reported with “IP” and a mutation (X420W) in the IKK-
gamma stop codon (Smahi et al. 2000). Heterozygous
females had no clinical signs of immunodeficiency, al-
though IgA levels were elevated in two females in family
2. Female carriers had variable manifestations, ranging
from normal dentition to minor degrees of hypodontia
and conical teeth. Two females had areas of spotty hy-
perpigmentation of the skin, but none reported earlier
inflammatory vesicles of the skin.
It is apparent from these data that different muta-
tions within IKK-gamma can produce markedly differ-
ent phenotypes in hemizygous males and heterozygous
females. Mutations that produce a complete loss of
IKK-gamma function result in a phenotype of IP, an X-
linked dominant trait with affected males dying in utero,
and heterozygous females having variable defects of
skin, hair, teeth, brain, and eye (Landy and Donnai
1993). A common genomic rearrangement, deletion of
exons 4–10, accounts for 80% of new mutations in clas-
sical IP (Smahi et al. 2000). Heterozygous females dis-
play nonrandom X inactivation and thus have surviving
T and B cells expressing only the wild-type IKK-gamma
allele (Parrish et al. 1996). Therefore, immunodeficiency
is not part of their phenotype. Murine knockout exper-
iments confirm that complete loss of IKK-gamma func-
tion is embryonic lethal in hemizygous males and pro-
duces a phenotype in heterozygous females that is similar
to IP (Makris et al. 2000; Rudolph et al. 2000; Schmidt-
Supprian et al. 2000). Evidence that IKK-gamma is es-
sential for T and B cell viability can be seen in hetero-
zygous knockout females (Ikk-gamma /) of age 9 d,
who have an extremely small thymus with destruction
of cortical lymphocytes as the result of increased apop-
tosis (Makris et al. 2000). Furthermore, chimeric mice
made from IKK-gamma–deficient embryonic stem cells
(/) have no detectable embryonic stem cell–derived
(/) B or T cells (Schmidt-Supprian et al. 2000). In
contrast with classical IP, mutations within exon 10 of
IKK-gamma produce an X-linked recessive disorder af-
fecting only males. All four mutations within exon 10
either delete or alter a putative zinc-finger domain
(amino acids 397–417) at the C-terminal end of the pro-
tein, and deletion of this domain is reported to result in
a loss of function of NF-kB activation (Smahi et al.
2000). The C-terminal region of the IKK-gamma protein
is believed to connect the IKK complex to its upstream
activators (Rothwarf et al. 1998). Deletion of the car-
boxy-terminal end of IKK-gamma has been shown to
markedly diminish, but not completely eliminate, stim-
ulation of NF-kB by Tax, the product of the type 1 hu-
man leukemia virus (Harhaj and Sun 1999; Xiao et al.
2000). The mutations seen in HED-ID must preserve
partial IKK-gamma function, since hemizygous males
survive and have normal numbers of T and B cells, albeit
with dysgammaglobulinemia and a defective ability to
produce some specific antibodies. Additional undefined
immunological defects likely exist, in addition to the
dysgammaglobulinemia, since IVIG therapy is not pro-
tective against recurrent infections by S. pneumoniae. It
remains to be determined whether the immunological
defects are due solely to IKK-gamma’s role in regulation
of the NF-kB pathway or whether other signaling path-
ways are involved. Defects in immunoglobulin isotype
switching are seen in humans and mice deficient in
CD40-mediated signaling. This signaling pathway is de-
pendent on the activation of multiple transcription fac-
tors, including NF-kB (Pype et al. 2000). NF-kB is a
heterodimeric transcription factor composed of various
combinations of structurally related proteins, including
p50, p65, and p52 (Kaufman and Fuchs 2000). In mice,
separate targeted disruptions of p50 and p65 produce
defects in lymphocyte development and function (Sha et
al. 1995; Doi et al. 1997). Furthermore, a double p50/
p52 knockout in mice blocks both B-cell and osteoclast
maturation, the latter causing osteopetrosis (Franzoso et
al. 1997). Targeted disruption of the receptor activator
of NF-kB, a member of the TNFR superfamily, also
causes osteopetrosis and B-cell defects in mice (Dougall
et al. 1999). Finally, these data provide further evidence
that the development of teeth and eccrine sweat glands
is mediated by the IKK protein complex. The ectodermal
defects in HED-ID are very similar to those seen in the
X-linked and autosomal forms of HED and suggest that
the protein products of these loci, members of the TNF/
TNFR superfamily, may regulate upstream activators of
the IKK signalsome complex.
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